Explore more about: Breast Cancer

The National Institutes of Health and the higher education non-profit VentureWell have selected 10 winners and five honorable mentions of the Design by Biomedical Undergraduate Teams (DEBUT) Challenge, who are set to receive prizes totaling $145,000. The awards will be presented to the winning teams during the annual Biomedical Engineering Society conference held Oct. 11-14, 2023.

Nanozymes—artificial enzymes that can carry out pre-determined chemical reactions—could selectively activate a cancer drug within a tumor while minimizing damage to healthy tissue in a mouse model of triple negative breast cancer.

One team helped develop the first photon-counting detector (PCD)-CT system, which is superior to current CT technology. Another team has also been using artificial intelligence to lower the dose of radiation given to a patient when they are undergoing a conventional CT brain scan.

NIBIB-funded researchers are developing an imaging method that would allow surgeons to better identify cancerous cells in breast tumor margins during surgery. This technique could lead to a reduction in follow-up breast cancer surgeries and reduce rates of breast cancer recurrence.

Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks. Researchers simulated an attack that falsified mammogram images, fooling both an AI breast cancer diagnosis model and human breast imaging radiologist experts.

While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment. A new cancer vaccine successfully treated immune-resistant breast cancer in mice, 100% of which survived a second injection of cancer cells, indicating long-term immunity with no side effects.

QuantX backstops radiologists with AI-enabled software that analyzes MRIs to confirm or challenge their diagnosis.

Learn about Dr. Carla Pugh's scientific accomplishments throughout her career journey and her advice for women scientists.

Macrophages are white blood cells that accumulate in tumors, where they aid cancer progression. Now scientists have identified a surface protein found only on the macrophages residing in tumors, exposing a target for precise tumor treatments.

NIBIB-funded researchers used photoacoustic imaging for rapid measurement of metabolic rate of individual cells from breast tumors—information that can help guide treatment strategies.